Marianne Elisabeth Klinke, a professor at the University of Iceland and head of the neurology and neurorehabilitation department at Landspitali, emphasizes that there is still limited knowledge about women with Parkinson's disease. She is actively seeking women with the disease to participate in a new Nordic study that aims to explore these gender-based differences. The research is significant as it recognizes that the manifestation of Parkinson's may differ between women and men, a consideration that has been overlooked in many previous studies.

Recent evidence suggests that hormonal changes throughout a woman's life can influence the symptoms and progression of Parkinson's disease. The study, which has already recruited over 1,700 women from the Nordic countries, aims to investigate how these hormonal fluctuations related to menstruation and pregnancy may affect treatment outcomes as well. Marianne highlights that the longstanding focus on gender-neutral research in this field has been inadequate and calls for a more inclusive approach that considers the unique experiences of women.

Overall, this research holds important implications for the understanding and management of Parkinson's disease in women, potentially leading to tailored therapeutic strategies that take into account the hormonal impacts on the condition. As more studies continue to highlight the gender differences in neurodegenerative diseases, there is hope for improved care and a deeper understanding of how these diseases can manifest differently based on sex, especially in hormonal contexts.